CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Ivana Magovcevic-Liebisch, Executive Vice President of Administration and General Counsel of Dyax, will present at the 29th Annual Canaccord Adams Global Growth Conference, being held August 11-13th at The Intercontinental Hotel in Boston, MA. Dr. Magovcevic-Liebisch will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax presentation is scheduled for Wednesday, August 12th at 3:30 PM (ET).
